Sequana Medical
De berekende faillissementskans van Sequana Medical over 12 maanden bedraagt 0,7% (laag). Het bedrijf is actief sinds 2018 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 7 jaar |
| Bestuur | 9 |
| Vestigingen | 1 |
| Publicaties | 200 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 13-06-2025 | 2025-00154228 |
| 31-12-2024 | consolidatie | 20-06-2025 | 2025-00160296 |
| 31-12-2023 | volledig | 12-06-2024 | 2024-00131040 |
| 31-12-2023 | consolidatie | 11-06-2024 | 2024-00131092 |
| 31-12-2022 | volledig | 26-05-2023 | 2023-00097142 |
| 31-12-2022 | consolidatie | 26-05-2023 | 2023-00100459 |
| 31-12-2021 | volledig | 27-06-2022 | 2022-20146864 |
| 31-12-2021 | consolidatie | 27-06-2022 | 2022-20109538 |
| 31-12-2020 | volledig | 18-06-2021 | 2021-21800275 |
| 31-12-2020 | consolidatie | 18-06-2021 | 2021-21800271 |
-
Actief10-11-2023 → heden
-
Actief10-02-2023 → heden
-
Actief02-09-2021 → heden
-
WIOT BVRechtspersoonBestuurder· vast vert.: Wim OttevaereStaatsblad-akte 21076641 (28-06-2021)Actief28-06-2021 → heden
-
Actief23-11-2018 → heden
3 gebeurtenissen
- 28-06-2021 Mandaat verlengd· Bestuurder
- 23-11-2018 Ontslagen· Bestuurder
- 23-11-2018 Benoemd· Bestuurder
-
Actief23-11-2018 → heden
2 gebeurtenissen
- 28-06-2021 Mandaat verlengd· Bestuurder
- 23-11-2018 Benoemd· Bestuurder
-
Actief23-11-2018 → heden
2 gebeurtenissen
- 28-06-2021 Mandaat verlengd· Bestuurder
- 23-11-2018 Benoemd· Bestuurder
-
Actief23-11-2018 → heden
3 gebeurtenissen
- 28-06-2021 Mandaat verlengd· Bestuurder
- 23-11-2018 Ontslagen· Bestuurder
- 23-11-2018 Benoemd· Bestuurder
-
Actief23-11-2018 → heden
Voormalige bestuurders (4)
-
Voormalig10-02-2023 → 30-11-2024
2 gebeurtenissen
- 30-11-2024 Ontslagen· Bestuurder
- 10-02-2023 Benoemd· Bestuurder
-
Voormalig26-06-2023 → 22-11-2024
2 gebeurtenissen
- 22-11-2024 Ontslagen· Bestuurder
- 26-06-2023 Benoemd· Bestuurder
-
Voormalig31-07-2019 → 02-09-2021
2 gebeurtenissen
- 02-09-2021 Ontslagen· Bestuurder
- 31-07-2019 Benoemd· Bestuurder
-
Voormalig— → 23-11-2018
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| BV PwC BedrijfsrevisorenActief Bedrijfsrevisor · vertegenwoordigd door Wouter Coppens |
— | 28-06-2021 → heden |
| PWC Bedrijfsrevisoren BCVBAActief Bedrijfsrevisor · vertegenwoordigd door Peter D'hondt |
— | 18-01-2019 → heden |
| NACE primair | 32500 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 01-10-2018 |
| Status | Actief |
| Postcode | 9051 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 44062B0064/00A004 | Vlaanderen | 1.419 m² | 1 · 600 m² | 15,8 m |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
08-05-2026 Kapitaalverhoging van €8.098.969,31 tot €8.098.969,31
- €0 → €8.098.969,31
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8098969.31,
"delta_eur": 8098969.31,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": 212028.44,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 78172033,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.4581
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 8098969.31,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-05-08",
"filing_date": "2026-05-06",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-04-08",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": []
}08-05-2026 Kapitaalverhoging van €273.996,68 tot €8.098.969,31
- €7.824.972,63 → €8.098.969,31
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8098969.31,
"delta_eur": 273996.6799999997,
"before_eur": 7824972.63,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}20-04-2026 Kapitaalverhoging van €401.125,02 tot €8.438.125,02
- €8.037.000 → €8.438.125,02
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8438125.02,
"delta_eur": 401125.02,
"before_eur": 8037000.0,
"share_emission": {
"agio_eur": 312667.3,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 853839,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.4698
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 401125.02,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-04-20",
"filing_date": "2026-04-16",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2026-03-26",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"substitutievolmacht",
"overzicht van inschrijvingen op nieuwe aandelen",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}20-04-2026 Kapitaalverhoging van €726.126.223 tot €803.700.107
- €77.573.884 → €803.700.107
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 803700107,
"delta_eur": 726126223,
"before_eur": 77573884,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}20-04-2026 Kapitaalverhoging van €88.457,72 tot €8.037.001,07
- €7.948.543,35 → €8.037.001,07
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 401125.02,
"currency": "EUR",
"after_eur": 8037001.07,
"delta_eur": 88457.72,
"before_eur": 7948543.35,
"amount_type": "totale_inbreng",
"effective_date": "2026-03-26",
"evidence_quote": "de kapitaalverhoging ... tot beloop van een totaal bedrag (inclusief uitgiftepremie) van vierhonderd\u00E9\u00E9nduizend honderdvijfentwintig euro twee cent (EUR 401.125,02) ... resulteert in een totaal bedrag in kapitaal van achtentachtigduizend vierhonderdzevenenvijftig euro twee\u00EBnzeventig cent (EUR 88.457,72) ... stelt vast dat bijgevolg deze kapitaalverhoging is tot stand gekomen, zodat het geplaatst kapitaal acht miljoen zevenendertigduizend \u00E9\u00E9n euro zeven cent (EUR 8.037.001,07) bedraagt",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}17-03-2026 Kapitaalverhoging van €227.102,70 tot €7.948.543,35
- €7.721.440,65 → €7.948.543,35
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1141682.36,
"currency": "EUR",
"after_eur": 7948543.35,
"delta_eur": 227102.7,
"before_eur": 7721440.65,
"amount_type": "totale_inbreng",
"effective_date": "2026-03-04",
"evidence_quote": "de kapitaalverhoging ... kan plaatsvinden op heden ... tot beloop van een totaal bedrag (inclusief uitgiftepremie) van \u00E9\u00E9n miljoen honderdeenenveertigduizend zeshonderdtwee\u00EBntachtig euro zesendertig cent (EUR 1.141.682,36) ... resulteert in een totaal bedrag in kapitaal van tweehonderdzevenentwintigduizend honderdtwee euro zeventig cent (EUR 227.102,70) ... VASTSTELLING De Verschijner stelt vast dat bijgevolg deze kapitaalverhoging is tot stand gekomen, zodat het geplaatst kapitaal zeven miljoen negenhonderdachtenveertigduizend vijfhonderddrie\u00EBnveertig euro vijfendertig cent (EUR 7.948.543,35) bedraagt",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}17-03-2026 Kapitaalverhoging van €1.141.682,35 tot €7.948.543,35
- €6.806.861 → €7.948.543,35
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7948543.35,
"delta_eur": 1141682.3499999996,
"before_eur": 6806861.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}17-03-2026 Kapitaalverhoging van €1.141.682,36 tot €9.090.225,71
- €7.948.543,35 → €9.090.225,71
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9090225.71,
"delta_eur": 1141682.36,
"before_eur": 7948543.35,
"share_emission": {
"agio_eur": 914579.66,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2192111,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.5208
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1141682.36,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-17",
"filing_date": "2026-03-13",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2026-03-04",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"substitutievolmacht",
"overzicht van inschrijvingen op nieuwe aandelen",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}13-02-2026 Kapitaalverhoging van €128.846,80 tot €7.721.440,65
- €7.592.593,85 → €7.721.440,65
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 704515.91,
"currency": "EUR",
"after_eur": 7721440.65,
"delta_eur": 128846.8,
"before_eur": 7592593.85,
"amount_type": "totale_inbreng",
"effective_date": "2026-01-26",
"evidence_quote": "de kapitaalverhoging ... kan plaatsvinden op heden ... tot beloop van een totaal bedrag (inclusief uitgiftepremie) van zevenhonderdvierduizend vijfhonderdvijftien euro eenennegentig cent (EUR 704.515,91) ... resulteert in een totaal bedrag in kapitaal van honderdachtentwintigduizend achthonderdzesenveertig euro tachtig cent (EUR 128.846,80) ... het geplaatst kapitaal zeven miljoen zevenhonderdeenentwintigduizend vierhonderdveertig euro vijfenzestig cent (EUR 7.721.440,65) bedraagt",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}13-02-2026 Kapitaalverhoging
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7721440.65,
"delta_eur": 704515.91,
"before_eur": 704515.91,
"share_emission": {
"agio_eur": 575669.11,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1243695,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.5665
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 704515.91,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-02-13",
"filing_date": "2026-02-11",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-04-08",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"overzicht van inschrijvingen op nieuwe aandelen",
"substitutie-volmacht",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}13-02-2026 Kapitaalverhoging van €704.515,91 tot €7.721.440,65
- €7.016.924,74 → €7.721.440,65
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7721440.65,
"delta_eur": 704515.9100000001,
"before_eur": 7016924.74,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}22-01-2026 Kapitaalverhoging van €1.259.253,85 tot €7.592.593,85
- €6.333.340 → €7.592.593,85
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7592593.85,
"delta_eur": 1259253.8499999996,
"before_eur": 6333340.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}22-01-2026 Kapitaalverhoging van €1.259.255,83 tot €8.851.849,68
- €7.592.593,85 → €8.851.849,68
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8851849.68,
"delta_eur": 1259255.83,
"before_eur": 7592593.85,
"share_emission": {
"agio_eur": 1052572.38,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1995014,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.6312
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1259255.83,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-22",
"filing_date": "2026-01-20",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-12-22",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": []
}22-01-2026 Kapitaalverhoging van €206.683,45 tot €7.592.593,85
- €7.385.910,40 → €7.592.593,85
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1259255.83,
"currency": "EUR",
"after_eur": 7592593.85,
"delta_eur": 206683.45,
"before_eur": 7385910.4,
"amount_type": "totale_inbreng",
"effective_date": "2025-12-22",
"evidence_quote": "kapitaalverhoging ... tot beloop van een totaal bedrag (inclusief uitgiftepremie) van \u00E9\u00E9n miljoen tweehonderdnegenenvijftigduizend tweehonderdvijfenvijftig euro drie\u00EBntachtig cent (EUR 1.259.255,83) ... totaal bedrag in kapitaal van tweehonderdzesduizend zeshonderddrie\u00EBntachtig euro vijfenveertig cent (EUR 206.683,45) ... geplaatst kapitaal zeven miljoen vijfhonderdtwee\u00EBnnegentigduizend vijfhonderddrie\u00EBnnegentig euro vijfentachtig cent (EUR 7.592.593,85) bedraagt",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}12-01-2026 Kapitaalverhoging van €5.107.000 tot €7.284.000
- €2.177.000 → €7.284.000
- 3 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 2177000.0,
"delta_eur": 1607000.0,
"before_eur": 570000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 3199326,
"contribution_amount_eur": 1607000.0
}
],
"share_emission": {
"agio_eur": 1275549.83,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 3199326,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 7284000.0,
"delta_eur": 5107000.0,
"before_eur": 2177000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2985668,
"contribution_amount_eur": 1500000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2985668,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.5024
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 331450.17,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 8284000.0,
"delta_eur": 1000000.0,
"before_eur": 7284000.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-12",
"filing_date": "2026-01-08",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-12-05",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"vijf (5) volmachten",
"Verslag van de Commissaris aan de Raad van Bestuur van Sequana Medical NV overeenkomstig artikel 7:198 juncto Artikel 7:197 van het Wetboek van Vennootschappen en Verenigingen",
"Verslag van de Raad van Bestuur overeenkomstig artikel 7:198 juncto artikelen 7:179 en 7:197 van het Wetboek van Vennootschappen en Verenigingen",
"Verslag van de Commissaris van de vennootschap overeenkomstig artikel 7:198 juncto artikel 7:179 van het Wetboek van Vennootschappen en Verenigingen",
"twee (2) conversiebevestigingen",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}12-01-2026 Kapitaalverhoging van €1.607.000 tot €7.385.910,40
- €5.778.910,40 → €7.385.910,40
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7385910.4,
"delta_eur": 1607000.0,
"before_eur": 5778910.4,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}12-01-2026 Kapitaalverhoging van €1.331.450,17 tot €7.385.910,40
- €6.054.460,23 → €7.385.910,40
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1607000.0,
"currency": "EUR",
"after_eur": 7385910.4,
"delta_eur": 1331450.17,
"before_eur": 6054460.23,
"amount_type": "totale_inbreng",
"effective_date": "2025-12-05",
"evidence_quote": "Het kapitaal zal worden verhoogd met een totaalbedrag van \u00E9\u00E9n miljoen zeshonderdzevenduizend euro (EUR 1.607.000,00) (inclusief uitgiftepremie) door middel van verschillende inbrengen in natura ... door uitgifte van in totaal drie miljoen honderdnegenennegentigduizend driehonderdzesentwintig (3.199.326) nieuwe aandelen",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}01-12-2025 Kapitaalverhoging van €1.540.984,57 tot €7.054.460,23
- €5.513.475,66 → €7.054.460,23
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 7054460.23,
"delta_eur": 1540984.5700000003,
"before_eur": 5513475.66,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}01-12-2025 Kapitaalverhoging van €241.385 tot €7.054.460,23
- €6.813.075,23 → €7.054.460,23
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1540984.57,
"currency": "EUR",
"after_eur": 7054460.23,
"delta_eur": 241385.0,
"before_eur": 6813075.23,
"amount_type": "totale_inbreng",
"effective_date": "2025-11-14",
"evidence_quote": "de kapitaalverhoging ... kan plaatsvinden op heden ... tot beloop van een totaal bedrag (inclusief uitgiftepremie) van \u00E9\u00E9n miljoen vijfhonderdveertigduizend negenhonderdvierentachtig euro zevenenvijftig cent (EUR 1.540.984,57) ... resulteert in een totaal bedrag in kapitaal van tweehonderdeenenveertigduizend driehonderdvijfentachtig euro (EUR 241.385,00) ... VASTSTELLING De Verschijner stelt vast dat bijgevolg deze kapitaalverhoging is tot stand gekomen, zodat het geplaatst kapitaal zeven miljoen vierenvijftigduizend vierhonderdzestig euro drie\u00EBntwintig cent (EUR 7.054.460,23) bedraagt",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}01-12-2025 Kapitaalverhoging van €1.540.984,57 tot €8.595.444,80
- €7.054.460,23 → €8.595.444,80
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8595444.8,
"delta_eur": 1540984.57,
"before_eur": 7054460.23,
"share_emission": {
"agio_eur": 1299599.57,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2329971,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.6614
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1540984.57,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-12-01",
"filing_date": "2025-11-27",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-11-14",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"substitutievolmacht",
"overzicht van inschrijvingen op nieuwe aandelen",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}03-11-2025 Kapitaalverhoging van €1.813.075,23 tot €6.813.075,23
- €5.000.000 → €6.813.075,23
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6813075.23,
"delta_eur": 1813075.2300000004,
"before_eur": 5000000.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}03-11-2025 Kapitaalverhoging van €270.898,25 tot €6.813.075,23
- €6.542.176,98 → €6.813.075,23
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 270898.25,
"currency": "EUR",
"after_eur": 6813075.23,
"delta_eur": 270898.25,
"before_eur": 6542176.98,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-16",
"evidence_quote": "VASTSTELLING De Verschijner stelt vast dat bijgevolg deze kapitaalverhoging is tot stand gekomen, zodat het geplaatst kapitaal zes miljoen achthonderddertienduizend vijfenzeventig euro en drie\u00EBntwintig eurocent (EUR 6.813.075,23) bedraagt... Gezegd bedrag wordt geboekt: - voor een bedrag van kapitaal van tweehonderdzeventigduizend achthonderdachtennegentig euro en vijfentwintig eurocent (EUR 270.898,25) op de rekening \u0022KAPITAAL\u0022.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}03-11-2025 Kapitaalverhoging van €2.067.535,47 tot €8.880.610,70
- €6.813.075,23 → €8.880.610,70
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8880610.7,
"delta_eur": 2067535.47,
"before_eur": 6813075.23,
"share_emission": {
"agio_eur": 1796637.22,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2614848,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.7907
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 2067535.47,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Emmanuelle VAN HAMME",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-03",
"filing_date": "2025-10-30",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-10-16",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"substitutievolmacht",
"overzicht van inschrijvingen op nieuwe aandelen",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}22-10-2025 Kapitaalverhoging van €2.043.628
- 3 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 2043628.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 2592255,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 2379849,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2592255,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 2043628.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 212406,
"contribution_amount_eur": 214000.0
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2379849,
"contribution_amount_eur": 1829628.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2592255,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 268557.62,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 2043628.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 212406,
"contribution_amount_eur": 214000.0
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Kredietverstrekkers",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2379849,
"contribution_amount_eur": 1829628.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2592255,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 268557.62,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-10-22",
"filing_date": "2025-10-20",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-10-20",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"zes (6) volmachten",
"verslag van de raad van bestuur",
"verslag van de commissaris aan de raad van bestuur",
"verslag van de commissaris van de vennootschap",
"twee (2) conversiebevestigingen",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 62997054,
"class_name": "Gewone Aandelen",
"capital_share_eur": 6526841.49,
"voting_rights_per_share": 1.0
}
]
}22-10-2025 Kapitaalverhoging van €2.043.628 tot €6.526.841,49
- €4.483.213,49 → €6.526.841,49
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6526841.49,
"delta_eur": 2043628.0,
"before_eur": 4483213.49,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}22-10-2025 Kapitaalverhoging van €16.282,86 tot €6.558.459,84
- €6.542.176,98 → €6.558.459,84
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6558459.84,
"delta_eur": 16282.859999999404,
"before_eur": 6542176.98,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical"
}
}22-10-2025 Kapitaalverhoging van €268.557,62 tot €4.751.771,49
- €4.483.213,87 → €4.751.771,49
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 2043628.0,
"currency": "EUR",
"after_eur": 4751771.49,
"delta_eur": 268557.62,
"before_eur": 4483213.87,
"amount_type": "totale_inbreng",
"effective_date": "2025-09-26",
"evidence_quote": "Het kapitaal zal worden verhoogd met een totaalbedrag van twee miljoen drie\u00EBnveertig duizend zeshonderdachtentwintig euro (EUR 2.043.628,00) (inclusief uitgiftepremie) door middel van verschillende inbrengen in natura... waarbij een bedrag van tweehonderdachtenzestig duizend vijfhonderdzevenenvijftig euro twee\u00EBnzestig cent (EUR 268.557,62) werd geboekt als kapitaal",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}22-10-2025 Kapitaalverhoging van €15.335,49 tot €6.542.176,98
- €6.526.841,49 → €6.542.176,98
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 15335.49,
"currency": "EUR",
"after_eur": 6542176.98,
"delta_eur": 15335.49,
"before_eur": 6526841.49,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-09-26",
"evidence_quote": "De kapitaalverhoging is bijgevolg volgestort als volgt: (i) in kapitaal, ten belope van 100%; hetzij in totaal vijftienduizend driehonderdvijfendertig euro negenennveertig cent (15.335,49 EUR)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0707.821.866",
"name_full": "SEQUANA MEDICAL",
"legal_form": "NV"
}
}22-10-2025 Kapitaalverhoging van €45.508,43
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 45508.43,
"before_eur": null,
"share_emission": {
"agio_eur": 45508.43,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 413713,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.11
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 16282.86,
"n_shares_destroyed": null,
"not_yet_called_eur": 29225.57,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 63145080,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-10-22",
"filing_date": "2025-10-20",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": null,
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"zes (6) volmachten",
"verslag van de raad van bestuur",
"beoordelingsverslag van de commissaris",
"drie (3) documenten inschrijving en instructie",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}19-09-2025 Kapitaalverhoging
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8100000.0,
"delta_eur": 1841636.25,
"before_eur": 6258283.87,
"share_emission": {
"agio_eur": 1647386.25,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1875000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.9822
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1841636.25,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-09-19",
"filing_date": "2025-09-17",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-09-08",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2025-04-08"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0707.821.866",
"name_full": "Sequana Medical",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"substitutievolmacht",
"overzicht van inschrijvingen op nieuwe aandelen",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | Sequana Medical |